Jump to ContentJump to Main Navigation
Show Summary Details

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR increased in 2015: 3.017
Rank 5 out of 30 in category Medical Laboratory Technology in the 2014 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR) 2015: 0.873
Source Normalized Impact per Paper (SNIP) 2015: 0.982
Impact per Publication (IPP) 2015: 2.238

See all formats and pricing
Volume 46, Issue 8 (Aug 2008)


The influence of smoking and homocysteine on subclinical atherosclerosis is modified by the connexin37 C1019T polymorphism – The Cardiovascular Risk in Young Finns Study

Auni Collings
  • 1Centre for Laboratory Medicine, Tampere University Hospital, and Tampere University Medical School, Tampere, Finland
/ Olli T. Raitakari
  • 2Department of Clinical Physiology, University of Turku, Turku, Finland
/ Markus Juonala
  • 3Department of Medicine, University of Turku, Turku, Finland
/ Kristiina Mansikkaniemi
  • 4Cardiovascular Research Centre, University of Turku, Turku, Finland
/ Mika Kähönen
  • 5Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland
/ Nina Hutri-Kähönen
  • 6Department of Paediatrics, Tampere University Hospital, Tampere, Finland
/ Jukka Marniemi
  • 7Department of Health and Functional Capacity, Population Research Laboratory, National Public Health Institute, Turku, Finland
/ Jorma S.A. Viikari
  • 8Department of Medicine, University of Turku, Turku, Finland
/ Terho J. Lehtimäki
  • 9Centre for Laboratory Medicine, Tampere University Hospital, and Tampere University Medical School, Tampere, Finland
Published Online: 2008-06-20 | DOI: https://doi.org/10.1515/CCLM.2008.216


Background: A polymorphism C1019T on the connexin37 (Cx37) gene has been found to associate with coronary artery disease. There are conflicting results on which allele confers risk, and the possibility of interactions between the polymorphism and risk factors has been raised. In this study, we examined interactions between the Cx37 polymorphism and common risk factors and their associations to early vascular parameters of atherosclerosis: carotid artery intima-media thickness (IMT), and carotid artery compliance (CAC) and brachial artery flow mediated dilatation (FMD).

Methods: A population of 1440 healthy young adults from the Cardiovascular Risk in Young Finns Study was studied. The subjects were genotyped and their cardiovascular risk factor and ultrasound data gathered in 2001 were used for the statistical analyses.

Results: In the whole population, homocysteine in subjects with the TT genotype was found to be associated with higher FMD values (p for interaction 0.038) and remained so in three different adjusted models (p for interaction 0.022–0.038). In women with the CC genotype, smoking was found to be associated with higher FMD values and the smoking-by-genotype interaction remained significant in three adjusted models (p for interaction 0.001–0.041). In women with TT genotype, the effect of smoking was opposite, i.e., FMD values for smokers were lower compared to non-smokers. In men, physical activity interacted with Cx37 on CAC in the CT and TT genotypes (p for interaction 0.011). No significant interactions were found to predict IMT.

Conclusions: The effect of smoking and homocysteine levels on arterial endothelial functions and elasticity were modified by the allelic variation of the Cx37 gene. These data suggest that variation in the connexin gene may modify effects risk factors have on vascular function.

Clin Chem Lab Med 2008;46:1102–8.

Keywords: atherosclerosis; brachial artery flow mediated dilatation; carotid artery compliance; connexin37; interaction; intima-media thickness; polymorphism

About the article

Corresponding author: Auni Collings, MD, Tampere University Hospital, Centre for Laboratory Medicine, P.O. Box 2000, 33521 Tampere, Finland Phone: +358-3-311-75622, Fax: +358-3-311-75554,

Received: 2008-01-01

Accepted: 2008-03-31

Published Online: 2008-06-20

Published in Print: 2008-08-01

Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2008.216. Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Jan Pitha, Ivana Králová Lesná, Jaroslav A. Hubáček, Alena Sekerková, Věra Lánská, Věra Adámková, Maria Dorobantu, Rodica Nicolescu, Robert Steiner, Vedrana Ivić, Attila Borbely, Zoltan Papp, and Sandor G. Vari
Atherosclerosis, 2015
J. Pitha, P. Pithova, and J. A. Hubacek
Biopolymers and Cell, 2011, Volume 27, Number 2, Page 118
Sandrine Morel, Laurent Burnier, and Brenda R. Kwak
Seminars in Immunopathology, 2009, Volume 31, Number 1, Page 49

Comments (0)

Please log in or register to comment.
Log in